Nucleostemin interacts with SMAD3 promoting tumor metastasis

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• SMAD3 is a key regulator in TGF-β signaling pathways, influencing development and disease.
• Understanding the regulation of SMAD3 activity is crucial for comprehending disease pathogenesis.

Purpose of the Study:

• To investigate the interaction between Nucleostemin (NS) and SMAD3.
• To elucidate the role of NS in SMAD3 activity and TGF-β signaling.
• To evaluate the impact of NS on cancer progression and metastasis.

Main Methods:

• Co-immunoprecipitation assays to confirm SMAD3-NS interaction.
• Western blotting to assess SMAD3 phosphorylation and dephosphorylation.
• In vitro cell migration and invasion assays.
• In vivo metastasis models in mice.
• Analysis of NS expression in human cancer tissues.

Main Results:

• Nucleostemin (NS) directly interacts with SMAD3, promoting its nuclear translocation and enhancing its activity post-TGF-β1 stimulation.
• NS competitively inhibits PPM1A from dephosphorylating SMAD3.
• NS promotes epithelial-mesenchymal transition (EMT), enhancing cellular migration and invasion in vitro.
• NS knockdown significantly reduces tumor metastasis in vivo.
• Elevated NS expression in human malignancies correlates with poor prognosis.

Conclusions:

• Nucleostemin (NS) functions as an oncogene by modulating SMAD3 activity and promoting cancer metastasis.
• NS represents a potential therapeutic target for various human cancers.